Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA). (Q34370489)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

review article

1 reference

title

Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

author name string

C M Gibson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

S J Marble

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

publication date

1 September 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

volume

24

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

page(s)

577-584

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

Incidence and predictors of bleeding after contemporary thrombolytic therapy for myocardial infarction. The Global Utilization of Streptokinase and Tissue Plasminogen activator for Occluded coronary arteries (GUSTO) I Investigators

11 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240903

Stroke after thrombolysis. Mortality and functional outcomes in the GUSTO-I trial. Global Use of Strategies to Open Occluded Coronary Arteries.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240903

Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction. Participants in the National Registry of Myocardial Infarction 2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240903

Cardiovascular disease in women: a statement for healthcare professionals from the American Heart Association. Writing Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240903

New plasminogen activators: a clinical review.

21 January 2018

1 reference

12 December 2020

Relationship between TIMI frame count and clinical outcomes after thrombolytic administration. Thrombolysis In Myocardial Infarction (TIMI) Study Group

1 reference

12 December 2020

Safety assessment of single-bolus administration of TNK tissue-plasminogen activator in acute myocardial infarction: the ASSENT-1 trial. The ASSENT-1 Investigators

1 reference

12 December 2020

1999 update: ACC/AHA Guidelines for the Management of Patients With Acute Myocardial Infarction: Executive Summary and Recommendations: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Comm

1 reference

12 December 2020

Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial

1 reference

12 December 2020

The ideal fibrinolytic: can drug design improve clinical results?

1 reference

12 December 2020

The language of lysis: a proposal to standardize the nomenclature

1 reference

12 December 2020

Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial. TIMI 10B Investigators

1 reference

12 December 2020

Improved Anticoagulation with a Weight-Adjusted Heparin Nomogram in Patients with Acute Coronary Syndromes: A Randomized Trial.

1 reference

12 December 2020

Thrombolysis medication errors: benefits of bolus thrombolytic agents

1 reference

12 December 2020

Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction.

1 reference

12 December 2020

RANDOMISED TRIAL OF INTRAVENOUS STREPTOKINASE, ORAL ASPIRIN, BOTH, OR NEITHER AMONG 17 187 CASES OF SUSPECTED ACUTE MYOCARDIAL INFARCTION: ISIS-2

1 reference

12 December 2020

Randomised, double-blind comparison of reteplase double-bolus administration with streptokinase in acute myocardial infarction (INJECT): trial to investigate equivalence. International Joint Efficacy Comparison of Thrombolytics

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients. Fibrinolytic Therapy Trialists' (FTT) Collabo

1 reference

12 December 2020

A faster-acting and more potent form of tissue plasminogen activator

1 reference

12 December 2020

Non-invasive prediction of reperfusion and coronary artery patency by continuous ST segment monitoring in the GUSTO-I trial

1 reference

12 December 2020

TNK-tissue plasminogen activator in acute myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 10A dose-ranging trial

1 reference

12 December 2020

An evaluation of empiric vs. nomogram-based dosing of heparin in an intensive care unit.

1 reference

12 December 2020

A comparison of reteplase with alteplase for acute myocardial infarction

1 reference

12 December 2020

Clinical predictors of early infarct-related artery patency following thrombolytic therapy: importance of body weight, smoking history, infarct-related artery and choice of thrombolytic regimen: the GUSTO-I experience. Global Utilization of Streptok

1 reference

12 December 2020

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators

1 reference

12 December 2020

Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1000 patients

1 reference

https://api.crossref.org/works/10.1002%2FCLC.4960240903

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1002/CLC.4960240903

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json

11 November 2019

PubMed publication ID

11558838

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11558838%20AND%20SRC:MED&resulttype=core&format=json